Singular Genomics Systems...

NASDAQ: OMIC · Real-Time Price · USD
20.01
0.00 (0.00%)
At close: Feb 20, 2025, 3:55 PM

Singular Genomics Systems Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
16.23M 74.27M 201.05M
Short-Term Investments
157.71M 170.31M 138.17M
Long-Term Investments
600K 1.71M 687K
Other Long-Term Assets
1.15M 2.86M 1.13M
Receivables
1.58M 2.01M 1.05M
Inventory
13.57M 18.22M 3.01M
Other Current Assets
1.46M 620K 761K
Total Current Assets
192.23M 268.43M 347.76M
Property-Plant & Equipment
71.49M 56.68M 6.07M
Goodwill & Intangibles
n/a -14.86M n/a
Total Long-Term Assets
73.24M 59.54M 7.89M
Total Assets
265.47M 327.98M 355.65M
Account Payables
2.59M 3.1M 2.35M
Deferred Revenue
-3.38M 4.58M n/a
Short-Term Debt
7.76M 6.32M n/a
Other Current Liabilities
-678K -2.63M 3.63M
Total Current Liabilities
18.29M 14.12M 6.74M
Long-Term Debt
8.9M 10.06M 9.9M
Other Long-Term Liabilities
650K 1.01M 2.83M
Total Long-Term Liabilities
68.17M 53.54M 12.73M
Total Liabilities
86.46M 67.65M 19.48M
Total Debt
75.29M 58.84M 9.9M
Common Stock
7K 7K 7K
Retained Earnings
-337.6M -242.78M -151.9M
Comprehensive Income
155K -837K -138K
Shareholders Equity
179.01M 260.32M 336.17M
Total Investments
158.31M 172.02M 138.86M